High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma

Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GPC1 levels...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Zhou, Cong‐ya, Dong, Yi‐ping, Sun, Xiao, Sui, Xin, Zhu, Hong, Zhao, Ya‐qin, Zhang, Yuan‐yuan, Mason, Clifford, Zhu, Qing, Han, Su‐xia
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6246926/
https://ncbi.nlm.nih.gov/pubmed/30358133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1833
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky